GL1X · GenesisL1 explorer

Research workbench

Crystal structure of CYP2C9 in complex with multiple losartan molecules

Analyse Crystal structure of CYP2C9 in complex with multiple losartan molecules in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5XXI
Type
protein
Length
463 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cytochrome P450 2C9
EC
1.14.13.-, 1.14.13.80, 1.14.13.48, 1.14.13.49, 1.14.99.38
UniProt
P11712
Ligands
LSN, HEM, K
Pockets
3 · best druggability 0.88

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytochrome P450 2C9 (EC 1.14.13.-, 1.14.13.80, 1.14.13.48, 1.14.13.49, 1.14.99.38)protein46349% helix, 9% strandP11712

Ligands and binding sites

  • LSN · [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol · ligand · 3 copies · chains A
  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • K · Potassium ion · metal

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111180.880.89111LSN, HEM
21690.480.7722empty
3670.350.7714empty

Compared structures

  • 5XXI · Crystal structure of CYP2C9 in complex with multiple losartan molecules · the same entry in another collection · chain A against A, TM-score 1.00
  • P11712 · AlphaFold monomer V2.0 prediction for cytochrome P450 2C9 (P11712) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.